SLS Borrowing Constraints
Sellas Life Sciences Group (SLS) has been identified as having one of the highest borrow fees among stocks with significant short interest. High borrow fees are a classic indicator of a 'hard-to-borrow' status, often driven by limited supply and high demand from short sellers. Investors should be aware that elevated costs to maintain a short position can lead to rapid unwinding if the stock price fails to decline, potentially creating a squeeze environment.
Signal data sourced from Interactive Brokers. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.